Patents by Inventor Boitelo Theresiah Letsolo

Boitelo Theresiah Letsolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896645
    Abstract: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: February 13, 2024
    Assignee: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG
    Inventors: Stefan Franz Thomas Weiss, Boitelo Theresiah Letsolo, Kerrilyn Naidoo, Tyrone Chad Otgaar
  • Publication number: 20210169974
    Abstract: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
    Type: Application
    Filed: February 17, 2021
    Publication date: June 10, 2021
    Inventors: Stefan Franz Thomas Weiss, Boitelo Theresiah Letsolo, Kerrilyn Naidoo, Tyrone Chad Otgaar
  • Publication number: 20180325997
    Abstract: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
    Type: Application
    Filed: November 7, 2016
    Publication date: November 15, 2018
    Inventors: Stefan Franz Thomas Weiss, Boitelo Theresiah Letsolo, Kerrilyn Naidoo, Tyrone Chad Otgaar